Patent indicators for the technology life cycle development
Research PolicyPublished 21 February 2007
Reinhard Haupt, Martin Kloyer, Marcus Lange
Citations277
SJR quartileQ1
SJR score3.44
SNIP3.20
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Investments in a technology have to consider its current life cycle stage. The widespread approach of studying technology life cycles by measuring patent activity indices, especially patent applications, raises a practical problem: it requires the survey of all applications and applicants on a technological field. On the basis of an empirical study on pacemaker technology the paper identifies several patent indices as appropriate life cycle stage indicators which do not require the survey of the complete patent activity.
Keywords
Economics, Econometrics and FinanceBusiness, Management and Accounting
National Bureau of Economic ResearchThe NBER Patent Citation Data File: Lessons, Insights and Methodological Tools
3,620 Citations2001Bronwyn H. Hall, Adam B. Jaffe +1 more
The RAND Journal of EconomicsA Penny for Your Quotes: Patent Citations and the Value of Innovations
2,925 Citations1990Manuel Trajtenberg
The Economic JournalTime Paths in the Diffusion of Product Innovations
1,572 Citations1982Michael Gort, Steven Klepper
Research PolicyCitations, family size, opposition and the value of patent rights
1,484 Citations2002Dietmar Harhoff, F. M. Scherer +1 more
The RAND Journal of EconomicsThe Importance of Patent Scope: An Empirical Analysis
1,184 Citations1994Joshua Lerner
American Economic ReviewKnowledge Spillovers and Patent Citations: Evidence from a Survey of Inventors
886 Citations2000Adam B. Jaffe, Manuel Trajtenberg +1 more
Research PolicyDirect validation of citation counts as indicators of industrially important patents
793 Citations1991Michael Albert, Derek R. Avery +2 more
Research PolicyPatents as indicators of corporate technological strength
686 Citations1987Francis Narin, Elliot Noma +1 more
The Economic JournalInnovation, Diversity and Diffusion: A Self-Organisation Model
476 Citations1988Gerald Silverberg, Giovanni Dosi +1 more
Research PolicyDoes science push technology? Patents citing scientific literature
459 Citations2000Martin Meyer
International Journal of Management ReviewsMeasuring progress and evolution in science and technology – I: The multiple uses of bibliometric indicators
379 Citations2002Arnold Verbeek, Koenraad Debackere +2 more
World Patent InformationCitation rates to technologically important patents
366 Citations1981Mark P. Carpenter, Francis Narin +1 more
Research PolicyThe dynamics of technological innovation: the case of the pharmaceutical industry
336 Citations2001Basil Achilladelis, Nicholas Antonakis
Journal of Knowledge ManagementProfiting from intellectual capital
335 Citations1999Patrick H. Sullivan
The paper describes the steps for extracting value and outlines several ways to manage the firm’s IC assets, and explains how the Gathering has defined intellectual capital and how its member companies use their knowledge to the benefit of their respective organizations.
RePEc: Research Papers in EconomicsThe Quality of Ideas: Measuring Innovation with Multiple Indicators
217 Citations1999Jean O. Lanjouw, Mark Schankerman
Research PolicyThe state and technical innovation: a case study of the electrical vehicle in France
212 Citations1980Michel Callon
National Bureau of Economic ResearchThe Quality of Ideas: Measuring Innovation with Multiple Indicators
198 Citations1999Jean O. Lanjouw, Mark Schankerman
World Patent InformationPatent trends as a technological forecasting tool
189 Citations1983Richard S. Campbell
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)Taking technology to market
179 Citations1981David Ford, Christopher Ryan
Journal of Evolutionary EconomicsThe hunt for S -shaped growth paths in technological innovation: a patent study *
157 Citations1999Birgitte Andersen
International Journal of Industrial OrganizationHow does innovative activity change as industries mature?
136 Citations2001Anita M. McGahan, Brian S. Silverman
International Journal of Management ReviewsMeasuring progress and evolution in science and technology – II: The multiple uses of technometric indicators
102 Citations2002Koenraad Debackere, Arnold Verbeek +2 more
International Journal of Industrial OrganizationEvolutionary trends of industry variables
100 Citations1998Rajshree Agarwal
Research PolicyThe dynamics of technological innovation: The case of the chemical industry
97 Citations1990Basil Achilladelis, Albert B. Schwarzkopf +1 more
Research PolicyThe dynamics of technological innovation: The sector of antibacterial medicines
59 Citations1993Basil Achilladelis
An analysis of all the innovations that were introduced over the period 1935-1987, based on an analysis of the structure and research intensity of the innovating companies and through them, on the pharmaceutical industry and its geography provides insights in both innovation theory and the dynamics of technological innovation.
Patent Strategy: For Researchers and Research Managers
53 Citations1996H. Jackson Knight
TechnovationGains and pains from licensing—patent-portfolios as strategic weapons in the cardiac rhythm management industry
42 Citations1999Klaus Brockhoff, Holger Ernst +1 more
It is shown that a strong patent-portfolio can be an important strategic weapon in the pacemaker industry.
Patent Strategy: The Manager's Guide to Profiting from Patent Portfolios
25 Citations2001Anthony L. Miele
Drug Discovery TodayA patent strategy for genomic and research tool patents: are there any differences between the USA, Europe and Japan?
7 Citations2000Jeffrey L. Ihnen
The patenting of genomics and research tools, and its effects on the development of therapeutics are attracting considerable attention and it is imperative that a suitable global patent strategy be developed and followed to maximize both intellectual property rights and returns on R&D investment.
